1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > Mental Health Analysis & Statistics 2020 - Italy

Mental Health Analysis & Statistics 2020 - Italy

1-30 of about 100 reports

Diabetic Peripheral Neuropathy (DPN) - Epidemiology Forecast-2030

  • $ 3750
  • Aug 2020
  • 80 pages

‘Diabetic Peripheral Neuropathy (DPN) - Epidemiology Forecast-2030’ report deliver an in-depth understanding of the disease, historical & forecasted epidemiology trends of Diabetic Peripheral Neuropathy ...

  • Mental Health
  • Neurological Disorder
  • Pathology
  • Italy
  • United States

Angelman Syndrome Epidemiology Forecast to 2030

  • $ 3750
  • July 2020
  • 100 pages

‘Angelman Syndrome - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Angelman Syndrome epidemiology in the 7MM, i.e., the United States, ...

  • Mental Health
  • Neurological Disorder
  • Pathology
  • Italy
  • United States

Dementia with Diabetes - Epidemiology Forecast to 2030

  • $ 3750
  • July 2020
  • 90 pages

‘Dementia with Diabetes—Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted Dementia with Diabetes epidemiology in the United States, ...

  • Dementia
  • Mental Health
  • Italy
  • Japan
  • Forecast

Dravet Syndrome Epidemiology Forecast to 2030

  • $ 3750
  • July 2020
  • 100 pages

‘Dravet Syndrome – Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Dravet Syndrome epidemiology in the 7MM, i.e., the United States, ...

  • Mental Health
  • Neurological Disorder
  • Pathology
  • Italy
  • United States

Lennox Gastaut Syndrome - Epidemiology Forecast–2030

  • $ 3750
  • July 2020
  • 100 pages

‘Lennox Gastaut Syndrome (LGS) - Epidemiology Forecast - 2030’ report delivers an in-depth understanding of the Lennox Gastaut Syndrome (LGS), historical and forecasted epidemiology in the United States, ...

  • Mental Health
  • Neurological Disorder
  • Germany
  • Italy
  • United States

Treatment-resistant depression (TRD) - Epidemiology Forecast - 2030

  • $ 3750
  • June 2020
  • 100 pages

‘Treatment-resistant depression (TRD)– Epidemiology Forecast—2030’ report delivers an in-depth understanding of the Treatment-resistant depression, historical and forecasted epidemiology in the ...

  • Depression
  • Mental Health
  • Pathology
  • Therapy
  • Italy

Pompe Disease - Epidemiology Forecast to 2030

  • $ 3750
  • May 2020
  • 100 pages

‘Pompe Disease (PD) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Pompe Disease in the United States, EU5 (Germany, ...

  • Mental Health
  • Neurological Disorder
  • Pathology
  • Italy
  • United Kingdom

Frontotemporal Dementia (FTD)- Epidemiology Forecast to 2030

  • $ 3750
  • May 2020
  • 100 pages

‘Frontotemporal Dementia (FTD) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Frontotemporal Dementia in the United ...

  • Mental Health
  • Neurological Disorder
  • Pathology
  • Italy
  • United States

Postpartum Depression - Epidemiology Forecast to 2030

  • $ 3750
  • April 2020
  • 100 pages

‘Postpartum Depression (PPD) - Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted Postpartum Depression (PPD) epidemiology in the United ...

  • Depression
  • Mental Health
  • Germany
  • Italy
  • Forecast

Duchenne Muscular Dystrophy - Epidemiology Forecast to 2030

  • $ 3750
  • April 2020
  • 100 pages

‘Duchenne Muscular Dystrophy (DMD) - Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted Duchenne Muscular Dystrophy (DMD) epidemiology ...

  • Mental Health
  • Neurological Disorder
  • Pathology
  • Italy
  • United States

Adrenoleukodystrophy (ALD) - Epidemiology Forecast to 2030

  • $ 3750
  • April 2020
  • 83 pages

Overview ‘Adrenoleukodystrophy (ALD) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Adrenoleukodystrophy epidemiology in the 7MM, ...

  • Mental Health
  • Neurological Disorder
  • Italy
  • Japan
  • United States

Tumor Necrosis Factor Receptor Superfamily Member 16 - Pipeline Review, H1 2020

  • $ 3500
  • February 2020
  • 51 pages

Tumor Necrosis Factor Receptor Superfamily Member 16 - Pipeline Review, H1 2020 Summary Tumor Necrosis Factor Receptor Superfamily Member 16 (Low Affinity Neurotrophin Receptor p75NTR or Low Affinity ...

  • Mental Health
  • Therapy
  • Italy
  • Product Initiative
  • Dompe Farmaceutici S.p.A.

Italy Neurology Devices Market Outlook to 2025 - Hydrocephalus shunts, Interventional Neuroradiology, Minimally Invasive Neurosurgery and Others.

  • $ 5995
  • January 2020
  • 177 pages

Italy Neurology Devices Market Outlook to 2025 - Hydrocephalus shunts, Interventional Neuroradiology, Minimally Invasive Neurosurgery and Others. Summary new report, Italy Neurology Devices Market Outlook ...

  • Mental Health
  • Italy
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • Stryker Corporation

Multiple Sclerosis: Epidemiology Forecast to 2028

  • $ 3995
  • November 2019
  • 38 pages

Multiple Sclerosis: Epidemiology Forecast to 2028 Summary Multiple sclerosis (MS) is an autoimmune disease affecting principally the central nervous system that causes nerve sheath demyelination followed ...

  • Health Services
  • Mental Health
  • Neurological Disorder
  • Italy
  • Forecast

Embolotherapy Market

  • $ 4900
  • September 2019
  • 336 pages

Embolotherapy Market Research Report: By Product (Embolic Agents, Support Devices), Procedure (Transcatheter Arterial Embolization, Transarterial Radioembolization/Selective Internal Radiation Therapy, ...

  • Mental Health
  • Pathology
  • France
  • Italy
  • Demand

Latuda

  • $ 10000
  • March 2019
  • 39 pages

Latuda (lurasidone; Sumitomo Dainippon/Angelini) contains the atypical antipsychotic lurasidone, which acts as an antagonist of dopamine receptors D2, and serotonin receptors 5-HT2A. By inhibiting the ...

  • Mental Health
  • Pathology
  • Psychotic Disorder
  • Italy
  • Japan

Zambon Company SpA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • November 2018
  • 27 pages

Summary Zambon Company SpA (Zambon) is a manufacturer of pharmaceutical and fine chemical products.It offers pharmaceutical products for respiratory, central nervous system, pain management, women’s ...

  • Mental Health
  • Pharmaceutical
  • Italy
  • M&A
  • Zambon Company S.p.A.

Italy Neurology Devices Market Outlook to 2025 - Hydrocephalus Shunts, Interventional Neuroradiology Devices, Neurosurgical Products and Others

  • $ 5995
  • November 2018
  • 163 pages

Italy Neurology Devices Market Outlook to 2025 - Hydrocephalus Shunts, Interventional Neuroradiology Devices, Neurosurgical Products and Others Summary GlobalData’s new report, Italy Neurology Devices ...

  • Mental Health
  • Italy
  • B. Braun Melsungen AG
  • Medtronic, Inc.
  • Stryker Corporation

Drug Overview: Latuda

  • $ 10000
  • April 2018
  • 33 pages

Drug Overview  Latuda (lurasidone; Sumitomo Dainippon/Angelini) contains the atypical antipsychotic lurasidone, which acts as an antagonist of dopamine receptors D2, and serotonin receptors 5-HT2A. ...

  • Mental Health
  • Psychotic Disorder
  • Italy
  • Japan
  • Supply

EPIOMIC EPIDEMIOLOGY SERIES: EPILEPSY FORECAST IN 19 MAJOR MARKETS 2018–2028

  • $ 5577
  • April 2018
  • 86 pages

Black Swan Analysis Epiomic™ Epidemiology Forecast Report on Epilepsy in 19 Major Markets Epilepsy is a complex neurologic disorder characterised by the occurrence of seizures, divided into several types ...

  • Mental Health
  • Neurological Disorder
  • Pathology
  • Italy
  • Spain

EpiCast Report: Alzheimer’s Disease - Epidemiology Forecast to 2026

  • $ 3995
  • October 2017
  • 37 pages

EpiCast Report: Alzheimer’s Disease - Epidemiology Forecast to 2026 Summary Alzheimer’s disease (AD) is a subtype of dementia and is an irreversible, neurodegenerative brain disease of the elderly, ...

  • Dementia
  • Mental Health
  • Italy
  • Spain
  • Forecast

Datamonitor Healthcare Parkinson’s Disease KOL Interviews

  • $ 599
  • April 2017
  • 27 pages

March 16, 2017 Datamonitor Healthcare interviewed two neurologists, one based in Italy and the other in the US, to gauge their prescribing habits and views on current treatment options and challenges, ...

  • Mental Health
  • Pathology
  • Psychotic Disorder
  • Italy
  • United States

Europe Unipolar Depression Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Unipolar Depression patients study in a new report ‘Europe Unipolar Depression Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Depression
  • Mental Health
  • Pathology
  • Italy
  • Forecast

Europe Schizophrenia Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Schizophrenia patients study in a new report ‘Europe Schizophrenia Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Schizophrenia ...

  • Mental Health
  • Pathology
  • Psychotic Disorder
  • Italy
  • Forecast

Europe Parkinson%s Disease Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Parkinson's Disease patients study in a new report ‘Europe Parkinson's Disease Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Mental Health
  • Pathology
  • Psychotic Disorder
  • Europe
  • Italy

Europe Panic Disorder Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Panic Disorder patients study in a new report ‘Europe Panic Disorder Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Panic ...

  • Anxiety Disorder
  • Mental Health
  • Pathology
  • Italy
  • Forecast

Europe Obsessive Compulsive Disorder Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Obsessive Compulsive Disorder patients study in a new report ‘Europe Obsessive Compulsive Disorder Epidemiology and Patient Flow Analysis - 2017’. The report ...

  • Mental Health
  • Pathology
  • Personality Disorder
  • Europe
  • Italy

Europe Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Multiple Sclerosis patients study in a new report ‘Europe Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Mental Health
  • Neurological Disorder
  • Pathology
  • Italy
  • Forecast

Europe Major Depression Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Major Depression patients study in a new report ‘Europe Major Depression Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into ...

  • Depression
  • Mental Health
  • Pathology
  • Italy
  • Forecast

Europe Huntington’s Disease Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • January 2017
  • 1 pages

Fore Pharma announced the results of its Huntington’s Disease patients study in a new report ‘Europe Huntington’s Disease Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Dementia
  • Mental Health
  • Pathology
  • Europe
  • Italy

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on